Miroslav Malešević

1.4k total citations
49 papers, 1.1k citations indexed

About

Miroslav Malešević is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Miroslav Malešević has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Immunology. Recurrent topics in Miroslav Malešević's work include Signaling Pathways in Disease (27 papers), Peptidase Inhibition and Analysis (6 papers) and Chemical Synthesis and Analysis (6 papers). Miroslav Malešević is often cited by papers focused on Signaling Pathways in Disease (27 papers), Peptidase Inhibition and Analysis (6 papers) and Chemical Synthesis and Analysis (6 papers). Miroslav Malešević collaborates with scholars based in Germany, United States and Croatia. Miroslav Malešević's co-authors include Günter Fischer, Norbert Sewald, Cordelia Schiene‐Fischer, Ulf Strijowski, Gunter Fischer, Erik Prell, Brigitte von Brunn, Yue Ma‐Lauer, Albrecht von Brunn and Michael Bukrinsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Miroslav Malešević

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miroslav Malešević Germany 19 742 182 166 157 125 49 1.1k
Giordana Feriotto Italy 23 1.1k 1.4× 78 0.4× 151 0.9× 105 0.7× 43 0.3× 93 1.6k
Robert C. Boltz United States 18 679 0.9× 85 0.5× 311 1.9× 140 0.9× 72 0.6× 25 1.4k
Søren Skov Jensen Denmark 16 1.7k 2.3× 88 0.5× 198 1.2× 111 0.7× 74 0.6× 17 2.1k
Margaret M. Mc Gee Ireland 19 1.3k 1.8× 132 0.7× 228 1.4× 261 1.7× 50 0.4× 38 1.8k
Jeffrey S. Culp United States 13 676 0.9× 174 1.0× 117 0.7× 98 0.6× 58 0.5× 15 1.3k
Eric M. Billings United States 21 770 1.0× 86 0.5× 411 2.5× 205 1.3× 47 0.4× 28 1.8k
Yaxue Zhao China 17 782 1.1× 104 0.6× 86 0.5× 121 0.8× 22 0.2× 44 1.2k
Jessica Marinello Italy 20 1.4k 1.9× 125 0.7× 74 0.4× 302 1.9× 62 0.5× 29 1.7k
Vincent Mikol France 23 1.1k 1.4× 46 0.3× 230 1.4× 261 1.7× 47 0.4× 37 1.6k
Kabir H. Biswas Qatar 21 852 1.1× 166 0.9× 155 0.9× 73 0.5× 32 0.3× 52 1.4k

Countries citing papers authored by Miroslav Malešević

Since Specialization
Citations

This map shows the geographic impact of Miroslav Malešević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Malešević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Malešević more than expected).

Fields of papers citing papers by Miroslav Malešević

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miroslav Malešević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Malešević. The network helps show where Miroslav Malešević may publish in the future.

Co-authorship network of co-authors of Miroslav Malešević

This figure shows the co-authorship network connecting the top 25 collaborators of Miroslav Malešević. A scholar is included among the top collaborators of Miroslav Malešević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miroslav Malešević. Miroslav Malešević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haupt, Christian, Julian Baur, Armando Rodríguez, et al.. (2023). Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis. Amyloid. 30(4). 424–433. 3 indexed citations
2.
Soni, Sanooj, Kieran P. O’Dea, Miroslav Malešević, et al.. (2021). Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 204(4). 421–430. 11 indexed citations
3.
Perrucci, Gianluca Lorenzo, Erica Rurali, Maria Corlianò, et al.. (2020). Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients. Cells. 9(1). 154–154. 16 indexed citations
4.
Perrucci, Gianluca Lorenzo, Paola Songia, Donato Moschetta, et al.. (2020). Cyclophilin A inhibition as potential treatment of human aortic valve calcification. Pharmacological Research. 158. 104888–104888. 3 indexed citations
5.
Erdmann, Frank, Erik Prell, Günther Jahreis, Günter Fischer, & Miroslav Malešević. (2018). Screening for Selective Protein Inhibitors by Using the IANUS Peptide Array. ChemBioChem. 19(8). 789–792.
6.
Malešević, Miroslav, et al.. (2015). A Fluorescence‐Based Array Screen for Transglutaminase Substrates. ChemBioChem. 16(8). 1169–1174. 29 indexed citations
7.
Malešević, Miroslav, et al.. (2015). Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia. Molecular Medicine. 21(1). 657–664. 12 indexed citations
8.
Ernst, Katharina, Simon Langer, Eva Kaiser, et al.. (2014). Cyclophilin-Facilitated Membrane Translocation as Pharmacological Target to Prevent Intoxication of Mammalian Cells by Binary Clostridial Actin ADP-Ribosylated Toxins. Journal of Molecular Biology. 427(6). 1224–1238. 36 indexed citations
9.
Jahreis, Günther, et al.. (2012). The FKBP38 Catalytic Domain Binds to Bcl-2 via a Charge-sensitive Loop. Journal of Biological Chemistry. 287(23). 19665–19673. 15 indexed citations
10.
Malešević, Miroslav, Erik J. Stemmy, Jason P. Gigley, et al.. (2010). A Cell-Impermeable Cyclosporine A Derivative Reduces Pathology in a Mouse Model of Allergic Lung Inflammation. The Journal of Immunology. 185(12). 7663–7670. 47 indexed citations
11.
Gizatullina, Zemfira, Hanno Svoboda, Stefan Vielhaber, et al.. (2010). Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions. Mitochondrion. 11(3). 421–429. 14 indexed citations
12.
Malešević, Miroslav, Günther Jahreis, Stephan Wawra, Günter Fischer, & Christian Lücke. (2007). Conformational Consequences of Regio‐ and Stereoselective Disulfide Bridge Oxidation in a Cyclic Peptide. ChemBioChem. 9(1). 46–49. 3 indexed citations
14.
Schönherr, Roland, et al.. (2006). Inhibition of human ether à go‐go potassium channels by Ca2+/calmodulin binding to the cytosolic N‐ and C‐termini. FEBS Journal. 273(5). 1074–1086. 60 indexed citations
15.
Yu, Chao, Miroslav Malešević, Günther Jahreis, et al.. (2005). The Architecture of Protein–Ligand Binding Sites Revealed through Template‐Assisted Intramolecular Peptide–Peptide Interactions. Angewandte Chemie International Edition. 44(9). 1408–1412. 12 indexed citations
16.
Zimmermann, Dunja, et al.. (2005). Integrin α5β1 Ligands: Biological Evaluation and Conformational Analysis. ChemBioChem. 6(2). 272–276. 31 indexed citations
17.
Malešević, Miroslav, et al.. (2004). An improved method for the solution cyclization of peptides under pseudo-high dilution conditions. Journal of Biotechnology. 112(1-2). 73–77. 76 indexed citations
20.
Karminski‐Zamola, Grace, et al.. (1993). Synthesis of New Heteropolycyclic Bis-Carboxamide: 3,5-Dichloro- N , N ’( p -Chlorophenyl)dithieno [3,2-b:2’,3’-d]Furan-2,6-Carboxamide. Croatica Chemica Acta. 65(4). 847–849. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026